Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) EBT (2016 - 2025)

Historic EBT for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$4.9 billion.

  • Sanofi's EBT fell 38023.12% to -$4.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.9 billion, marking a year-over-year decrease of 729.19%. This contributed to the annual value of $8.3 billion for FY2025, which is 1380.38% down from last year.
  • According to the latest figures from Q4 2025, Sanofi's EBT is -$4.9 billion, which was down 38023.12% from $9.3 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's EBT ranged from a high of $11.3 billion in Q4 2022 and a low of -$4.9 billion during Q4 2025
  • Moreover, its 5-year median value for EBT was $2.6 billion (2025), whereas its average is $3.2 billion.
  • Its EBT has fluctuated over the past 5 years, first surged by 6788037.87% in 2022, then plummeted by 38023.12% in 2025.
  • Sanofi's EBT (Quarter) stood at -$16.7 million in 2021, then skyrocketed by 67880.38% to $11.3 billion in 2022, then fell by 12.87% to $9.9 billion in 2023, then plummeted by 82.17% to $1.8 billion in 2024, then crashed by 380.23% to -$4.9 billion in 2025.
  • Its last three reported values are -$4.9 billion in Q4 2025, $9.3 billion for Q3 2025, and $1.8 billion during Q2 2025.